Home / Companies / Charles River Laboratories International, Inc. / 20 May 2025
Charles River Laboratories International, Inc.: meeting of 20 May 2025
Votes reported on Form N-PX, item by item
792 Form N-PX filers reported votes at the Charles River Laboratories International, Inc. meeting of 20 May 2025. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
11 nominees; 91.0% of reported votes for; 55 filers withheld from or voted against at least one nominee.
5,414 vote records from 219 filers. 3 of the 218 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
1,166 vote records from 783 filers. 69 of the 757 filers that marked the item either way voted against management. 26 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
494 vote records from 219 filers. 9 of the 218 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
OTHER SOCIAL ISSUESSecurity holder
Report on Imported Nonhuman Primates
481 vote records from 213 filers. 33 of the 213 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor | 4. Proposal |
|---|---|---|---|---|
| Vanguard | For | For | For | Against |
| BlackRock and iShares | For | For | For | Against |
| Fidelity | For | For | For | Against |
| Dimensional | For | For | For | Against |
| State Street and SPDR | For | For | For | Against |
| American Century | For | Against * | For | Against |
| Franklin Templeton | For | For | For | Against |
| Invesco | For | For | For | Against |
| Equitable | For | For | For | Against |
| Charles Schwab | For | For | For | Against |
| Nuveen and TIAA | For | For | For | Against |
| ProShares and ProFunds | For | For | For | Against |
| John Hancock and Manulife | For | For | For | Against |
| Morgan Stanley, Eaton Vance and Calvert | For | For | For | For * |
| J.P. Morgan | For | For | For | Against |
| Goldman Sachs | For | For | For | Against |
| WisdomTree | For | For | For | Against |
| PGIM and Prudential | For | Against * | For | Against |
| Jackson National funds | For | For | For | Against |
| Northern Trust and FlexShares | For | For | For | Against |
| SEI | For | For | For | Against |
| T. Rowe Price | For | For | For | Against |
| Thrivent | For | For | For | Against |
| Lincoln Financial | For | For | For | For |
| Voya | For | For | For | Against |
| First Trust | For | For | For | Against |
| Russell Investments | For | For | For | Against |
| Nationwide | For | For | For | Against |
| Victory Capital | For | For | For | Against |
| Brighthouse Funds | For | For | For | Against |
| Guggenheim and Rydex | For | For | For | Against |
| Columbia Threadneedle | For | For | For | Against |
| BNY Mellon | For | For | Against * | Against |
| Principal | For | For | For | Against |
| Pacific Life funds | For | For | For | Against |
| Global X | For | For | For | No report |
| Transamerica | For | For | For | Against |
| Federated Hermes | For | For | For | Against |
| AllianceBernstein | For | For | For | Against |
| Hartford Funds | For | For | For | Against |
| DWS | For | For | For | For * |
| PIMCO | No report | For | No report | No report |
| Allspring | For | For | For | Against |
| MassMutual | For | For | For | Against |
| Virtus | For | For | For | Against |
| VanEck | For | For | For | Against |
| Janus Henderson | No report | For | No report | No report |
| Neuberger Berman | For | For | For | Against |
| Natixis and Loomis Sayles | For | For | For | Against |
| Lord Abbett | For | For | For | Against |
| Baird | No report | For | No report | No report |
| Artisan Partners | Split or no vote | Split or no vote | Split or no vote | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Charles River Laboratories International, Inc. meeting?
792 Form N-PX filers reported votes at the meeting of 20 May 2025. On say-on-pay, 69 of 757 voted against management (9.1%). One proposal from security holders could be told apart in the filings. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Charles River Laboratories International, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Charles River Laboratories International, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Charles River Laboratories International, Inc. with a meeting date within three days of 20 May 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.